Detalhe da pesquisa
1.
Effectiveness and safety of intravenous tocilizumab to treat COVID-19-associated hyperinflammatory syndrome: Covizumab-6 observational cohort.
Clin Immunol
; 223: 108631, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33189888
2.
Impact of IL6R genetic variants on treatment efficacy and toxicity response to sarilumab in rheumatoid arthritis.
Arthritis Res Ther
; 25(1): 226, 2023 11 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38001504
3.
Clinical Value of IL6R Gene Variants as Predictive Biomarkers for Toxicity to Tocilizumab in Patients with Rheumatoid Arthritis.
J Pers Med
; 13(1)2022 Dec 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36675722
4.
Role of IL6R Genetic Variants in Predicting Response to Tocilizumab in Patients with Rheumatoid Arthritis.
Pharmaceutics
; 14(9)2022 Sep 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36145690
5.
Krebs von den Lungen-6 glycoprotein circulating levels are not useful as prognostic marker in COVID-19 pneumonia: A large prospective cohort study.
Front Med (Lausanne)
; 9: 973918, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36004366
6.
Assessment of EULAR/ACR-2019, SLICC-2012 and ACR-1997 Classification Criteria in SLE with Longstanding Disease.
J Clin Med
; 10(11)2021 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34071275
7.
Rheumatoid Arthritis: Defining Clinical and Ultrasound Deep Remission.
Mediterr J Rheumatol
; 31(4): 384-388, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33521569